Verve Therapeutics

10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
Verve moves forward with backup base editing therapy
BioPharma Dive
Tue, 05/7/24 - 11:29 am
Verve Therapeutics
clinical trials
gene therapy
heart disease
First look at Verve study data offer base editing ‘proof of principle’
BioPharma Dive
Sun, 11/12/23 - 09:27 pm
Verve Therapeutics
heart disease
gene editing
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Tue, 10/31/23 - 10:06 am
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Verve gets FDA green light to run base editing study in US
BioPharma Dive
Mon, 10/23/23 - 05:01 pm
Verve Therapeutics
FDA
gene editing
heart disease
clinical trials
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Thu, 06/15/23 - 10:02 am
Eli Lilly
Verve Therapeutics
heart disease
gene editing
FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101
BioSpace
Mon, 12/5/22 - 10:55 pm
Verve Therapeutics
VERVE-101
FDA
heterozygous familial hypercholesterolemia
Do Verve's gene edits pass down to patients' children? The FDA wants to know
Fierce Biotech
Mon, 12/5/22 - 10:42 am
Verve Therapeutics
gene editing
gene therapy
FDA
VERVE-101
FDA Pauses Verve’s Trial Plan for Gene-Editing Therapy for High Cholesterol
MedCity News
Mon, 11/7/22 - 05:17 pm
Verve Therapeutics
gene editing
FDA
heterozygous familial hypercholesterolemia
VERVE-101
HeFH
Vertex, Verve team up to develop a gene editing drug for liver disease
Biopharma Dive
Wed, 07/20/22 - 11:24 pm
Vertex Pharma
Verve Therapeutics
liver disease
Biotech listings shows few signs of cooling
EP Vantage
Fri, 07/2/21 - 10:53 am
biotech
IPOs
Lyell Immunopharma
Recursion Pharmaceuticals
Centessa Pharmaceuticals
Verve Therapeutics
Graphite Bio
Another four IPOs complete busy week as biotech raise continues to match 2020's record pace
Endpoints
Fri, 06/18/21 - 10:06 am
IPOs
Lyell Immunopharma
Verve Therapeutics
Molecular Partners
ATAI Life Sciences
Century Therapeutics
Ambrx
Cyteir Therapeutics
Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO
Fierce Biotech
Tue, 06/1/21 - 10:50 pm
Verve Therapeutics
IPOs
gene editing
heart disease
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Tue, 01/19/21 - 09:13 pm
Beam Therapeutics
Verve Therapeutics
gene editing
funding
JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
Fierce Biotech
Tue, 01/12/21 - 11:11 am
JPMHC 2021
Verve Therapeutics
VERVE-101
familial hypercholesterolemia
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Stat
Sun, 06/28/20 - 07:10 pm
CRISPR
Verve Therapeutics
stem cells
cholesterol
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
Xconomy
Thu, 06/11/20 - 11:17 am
gene editing
Verve Therapeutics
heart attacks
familial hypercholesterolemia
Google Jumps Into Gene Editing: 5 Things You Need to Know
Motley Fool
Mon, 05/13/19 - 10:20 am
Google
gene editing
Verily
Verve Therapeutics
Alphabet
nanoparticles

Pages